125 related articles for article (PubMed ID: 3383034)
1. Maintaining remission of Crohn's disease.
Novak E
CMAJ; 1988 Jul; 139(1):14. PubMed ID: 3383034
[No Abstract] [Full Text] [Related]
2. Essential fatty acids and cancer with particular reference to Hodgkin's disease.
Singh NK; Das UN; Srivastava PK
J Assoc Physicians India; 1987 Feb; 35(2):137-8. PubMed ID: 3693269
[No Abstract] [Full Text] [Related]
3. Maintenance of remission in Crohn's disease: is 5'-aminosalicylic acid the answer?
Tremaine WJ
Gastroenterology; 1992 Aug; 103(2):694-6. PubMed ID: 1353043
[No Abstract] [Full Text] [Related]
4. Treatment of Crohn's disease with 5-ASA.
Katz J
Am J Gastroenterol; 1993 Sep; 88(9):1315-7. PubMed ID: 8362823
[No Abstract] [Full Text] [Related]
5. Maintenance treatment for Crohn's disease: has the time arrived?
Goldstein F
Am J Gastroenterol; 1992 May; 87(5):551-6. PubMed ID: 1350706
[No Abstract] [Full Text] [Related]
6. [Current salazosulfapyridine derivatives in the treatment of Crohn's disease].
Belaiche J; Delwaide J; Louis E; Gast P
Rev Med Liege; 1991 Jan; 46(1):16-22. PubMed ID: 2011676
[No Abstract] [Full Text] [Related]
7. Second trial of mesalamine therapy in the treatment of active Crohn's disease.
Singleton J
Gastroenterology; 1994 Aug; 107(2):632-3. PubMed ID: 8039647
[No Abstract] [Full Text] [Related]
8. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
Feurle GE; Helmstädter V
Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
[No Abstract] [Full Text] [Related]
9. Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis.
Messori A; Brignola C; Trallori G; Rampazzo R; Bardazzi G; Belloli C; d'Albasio G; De Simone G; Martini N
Am J Gastroenterol; 1994 May; 89(5):692-8. PubMed ID: 8172139
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Crohn's disease with peroral 5-aminosalicylic acid.
Rasmussen SN; Binder V; Maier K; Bondesen S; Fischer C; Klotz U; Hansen SH; Hvidberg EF
Gastroenterology; 1983 Dec; 85(6):1350-3. PubMed ID: 6354827
[TBL] [Abstract][Full Text] [Related]
11. Chemistry, pharmacology, pharmacokinetics, and clinical applications of mesalamine for the treatment of inflammatory bowel disease.
Small RE; Schraa CC
Pharmacotherapy; 1994; 14(4):385-98. PubMed ID: 7937276
[TBL] [Abstract][Full Text] [Related]
12. Mesalazine as maintenance treatment in Crohn's disease.
Vos J; Lesterhuis W
Gastroenterology; 1994 Feb; 106(2):553-4. PubMed ID: 8299923
[No Abstract] [Full Text] [Related]
13. 5-Aminosalicylates for prevention of recurrence in patients with Crohn's disease: time for a reappraisal?
Sutherland LR
J Clin Gastroenterol; 1991 Feb; 13(1):5-7. PubMed ID: 2007746
[No Abstract] [Full Text] [Related]
14. The role of mesalazine in Crohn's disease.
Hanauer SB
Scand J Gastroenterol Suppl; 1990; 172():56-9. PubMed ID: 1972296
[TBL] [Abstract][Full Text] [Related]
15. [Current medical therapies for Crohn's disease in Japan].
Munakata A; Haga Y
Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):406-11. PubMed ID: 9168493
[TBL] [Abstract][Full Text] [Related]
16. Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
Hanauer SB; Krawitt EL; Robinson M; Rick GG; Safdi MA
Am J Gastroenterol; 1993 Sep; 88(9):1343-51. PubMed ID: 8362827
[TBL] [Abstract][Full Text] [Related]
17. [Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders].
Gendre JP; Mary JY; Florent C; Modigliani R; Colombel JF; Soulé JC; Galmiche JP; Lerebours E; Descos L; Viteau JM
Ann Gastroenterol Hepatol (Paris); 1993 Oct; 29(5):251-6. PubMed ID: 8250520
[TBL] [Abstract][Full Text] [Related]
18. Melanoma and fatty acids.
Holborow P
N Z Med J; 1991 Jan; 104(904):19. PubMed ID: 2008253
[No Abstract] [Full Text] [Related]
19. Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?
Sahmoud T; Mary JY; Sahmoud T
Gut; 1997 Feb; 40(2):284-5. PubMed ID: 9071946
[No Abstract] [Full Text] [Related]
20. Acute pancreatitis in Crohn's disease due to 5-ASA therapy.
Radke M; Bartolomaeus G; Müller M; Richter I
J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):337-9. PubMed ID: 8492268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
